Ghost Tree Capital, LLC Tricida, Inc. Transaction History

Ghost Tree Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $1.7 Million - $2.72 Million	200,000 New	200,000 $2.1 Million
Q2 2019 Aug 14, 2019	SELL	$31.16 - $39.46 $4.67 Million - $5.92 Million	-150,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$19.96 - $38.62 $2 Million - $3.86 Million	-100,000 Reduced 40.0%	150,000 $5.79 Million
Q3 2018 Nov 14, 2018	BUY	$22.5 - $39.35 $1.44 Million - $2.52 Million	63,981 Added 34.39%	250,000 $7.64 Million
Q2 2018 Aug 14, 2018	BUY	$26.0 - $29.9 $4.84 Million - $5.56 Million	186,019 New	186,019 $5.56 Million

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.